Assesses the feasibility and reliability of Electrical Impedance Myography in ALS, suggesting its role as a progression biomarker.
Test the feasibility and reliability of at-home Electrical Impedance Myography (EIM) measurements collected via the Myolex mScan® device in individuals with amyotrophic lateral sclerosis (ALS), and to assess its potential as a biomarker of disease progression.
No takes yet. Share an insight, caveat, or question.
Cenci et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: